Literature DB >> 16357622

The role of dominant stenoses in bacterial infections of bile ducts in primary sclerosing cholangitis.

Juergen Pohl1, Axel Ring, Wolfgang Stremmel, Adolf Stiehl.   

Abstract

OBJECTIVE: Primary sclerosing cholangitis (PSC) is characterized by progressive fibrotic inflammation and strictures of the biliary system. We studied the role of dominant stenoses in bacterial biliary infections and the effect of routine antibiotic administration with cholangiography.
DESIGN: A prospective clinical trial without blinding or randomization.
SETTING: The endoscopy unit in a university hospital. PARTICIPANTS: Fifty patients with PSC entered and finished the study.
INTERVENTIONS: A total of 103 endoscopic retrograde cholangiographies (ERC) was performed in 37 PSC patients with dominant stenosis and 13 controls with PSC but no dominant stenosis. After selective cannulation of the bile duct, bile samples were obtained during each procedure. All patients received systemic antibiotic treatment with ciprofloxacin for one week after ERC.
RESULTS: Enteric bacteria were detected in the bile specimens of 15 out of 37 PSC patients (40.5%) with dominant stenosis but never in the absence of dominant stenosis (P=0.004). Positive cultures for enteric bacteria were associated with elevated serum C-reactive protein, high leukocyte counts in bile (P<0.05) and the deterioration of liver function assessed by increasing bilirubin levels during the follow-up period lasting a median of 7 months (P=0.06). Despite the high rate of susceptibility in vitro, ciprofloxacin treatment eradicated enteric bacteria in only two out of 12 cases.
CONCLUSION: Bacterial infection of the bile ducts with dominant stenosis is a frequent finding and may play a role in the progression of PSC. Short-course antibiotic treatment is not very effective in eradicating acteria from the bile ducts.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16357622     DOI: 10.1097/00042737-200601000-00012

Source DB:  PubMed          Journal:  Eur J Gastroenterol Hepatol        ISSN: 0954-691X            Impact factor:   2.566


  32 in total

1.  Primary sclerosing cholangitis: The importance of treating stenoses and infections.

Authors:  Jens J W Tischendorf; Ramin Schirin-Sokhan
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2009-12       Impact factor: 46.802

2.  Absence of the intestinal microbiota exacerbates hepatobiliary disease in a murine model of primary sclerosing cholangitis.

Authors:  James H Tabibian; Steven P O'Hara; Christy E Trussoni; Pamela S Tietz; Patrick L Splinter; Taofic Mounajjed; Lee R Hagey; Nicholas F LaRusso
Journal:  Hepatology       Date:  2015-08-10       Impact factor: 17.425

Review 3.  Analytical review of diagnosis and treatment strategies for dominant bile duct strictures in patients with primary sclerosing cholangitis.

Authors:  Murad Aljiffry; Paul D Renfrew; Mark J Walsh; Marie Laryea; Michele Molinari
Journal:  HPB (Oxford)       Date:  2011-02       Impact factor: 3.647

4.  The "gut microbiota" hypothesis in primary sclerosing cholangitis.

Authors:  Valerio Pontecorvi; Marco Carbone; Pietro Invernizzi
Journal:  Ann Transl Med       Date:  2016-12

5.  Microbial profile and antibiotic sensitivity pattern in bile cultures from endoscopic retrograde cholangiography patients.

Authors:  Muhsin Kaya; Remzi Beştaş; Fatma Bacalan; Ferhat Bacaksız; Esma Gülsun Arslan; Mehmet Ali Kaplan
Journal:  World J Gastroenterol       Date:  2012-07-21       Impact factor: 5.742

6.  Cutting edge issues in primary sclerosing cholangitis.

Authors:  Christopher L Bowlus
Journal:  Clin Rev Allergy Immunol       Date:  2011-10       Impact factor: 8.667

7.  Characterization of the gut microbiota in patients with primary sclerosing cholangitis compared to inflammatory bowel disease and healthy controls.

Authors:  Samaneh Ostadmohammadi; Masoumeh Azimirad; Hamidreza Houri; Kaveh Naseri; Ehsan Javanmard; Hamed Mirjalali; Abbas Yadegar; Amir Sadeghi; Hamid Asadzadeh Aghdaei; Mohammad Reza Zali
Journal:  Mol Biol Rep       Date:  2021-07-25       Impact factor: 2.316

8.  Presence of anti-microbial antibodies in liver cirrhosis--a tell-tale sign of compromised immunity?

Authors:  Maria Papp; Gary L Norman; Zsuzsanna Vitalis; Istvan Tornai; Istvan Altorjay; Ildiko Foldi; Miklos Udvardy; Zakera Shums; Tamas Dinya; Peter Orosz; Bela Lombay; Gabriella Par; Alajos Par; Gabor Veres; Timea Csak; Janos Osztovits; Ferenc Szalay; Peter Laszlo Lakatos
Journal:  PLoS One       Date:  2010-09-23       Impact factor: 3.240

Review 9.  Primary sclerosing cholangitis and the microbiota: current knowledge and perspectives on etiopathogenesis and emerging therapies.

Authors:  James H Tabibian; Steven P O'Hara; Keith D Lindor
Journal:  Scand J Gastroenterol       Date:  2014-07-03       Impact factor: 2.423

Review 10.  The immunobiology of primary sclerosing cholangitis.

Authors:  Jonathan H Aron; Christopher L Bowlus
Journal:  Semin Immunopathol       Date:  2009-05-26       Impact factor: 9.623

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.